- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07948707
Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management (remote monitor)
Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management Among Patients With Diabetes Mellitus
Diabetes mellitus is a chronic condition that often imposes significant psychological distress and requires complex daily self-management. This randomized controlled trial aims to evaluate the effectiveness of a structured nurse-led intervention combined with patient navigation on reducing psychological distress and improving self-management behaviors among patients with diabetes. Eligible adult patients with diabetes will be randomly assigned into either an intervention group receiving the nurse-led educational, psychosocial, and navigation support program alongside routine care, or a control group receiving routine diabetes care alone. Outcomes related to diabetes-related psychological distress and self-care adherence will be assessed at baseline and following the intervention period to determine the clinical impact of the program.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background and Rationale:
Living with diabetes requires continuous lifestyle modifications, medication adherence, and blood glucose monitoring, which frequently lead to diabetes-related psychological distress, anxiety, and burnout. High levels of psychological distress negatively affect treatment adherence and glycemic control. Nurse-led interventions coupled with patient navigation offer a holistic, patient-centered approach by providing tailored health education, emotional support, problem-solving skills, and assistance in overcoming healthcare system barriers.
Study Objective:
The primary objective of this study is to examine the effect of a nurse-led intervention and patient navigation program on psychological distress and diabetes self-management among patients with diabetes.
Study Design and Methodology:
This study utilizes a two-arm, parallel-group randomized controlled trial (RCT) design. After obtaining informed consent and completing baseline assessments, eligible participants will be randomly allocated in a 1:1 ratio into two equal groups:
- Intervention Group: Participants will receive a structured nurse-led intervention and patient navigation program in addition to standard care. The intervention encompasses individualized diabetes self-management education, psychological and coping support, goal setting, care coordination, and regular follow-up reminders to facilitate access to healthcare services and address barriers to care.
- Control Group: Participants will continue to receive their standard routine diabetes care without the additional navigation or nurse-led sessions.
Outcome Assessment:
Both groups will be evaluated at baseline (pre-test) and after completion of the intervention (post-test) using validated psychometric and behavioral instruments measuring diabetes-related psychological distress (such as the Diabetes Distress Scale) and diabetes self-management practices (such as the Summary of Diabetes Self-Care Activities). Data will be statistically analyzed to compare pre- and post-intervention changes within and between the two study groups.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Doaa mansour Ali, assisstant professor
- Número de teléfono: 01116240970
- Correo electrónico: dodo8836@yahoo.com
Ubicaciones de estudio
-
-
-
Cairo, Egipto
- Reclutamiento
- The study will be conducted at the Diabetes and Endocrinology Outpatient Clinics of Helwan General Hospital, a major secondary-level governmental healthcare facility operating under the Ministry of Health and Population in Cairo, Egypt.
-
Contacto:
- Doaa mansour Ali, assisstant professor
- Número de teléfono: 01116240970
- Correo electrónico: dodo8836@yahoo.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
Participants will be included in the study if they meet the following criteria:
- Adults aged 18 years or older.
- Patients with a confirmed diagnosis of type 1 or type 2 diabetes mellitus.
- Patients receiving routine diabetes care at the selected study setting.
- Patients who have access to a telephone or another suitable remote communication method.
- Patients who are willing to participate in the study and provide written informed consent.
- Patients who are able to understand and complete the study questionnaires in the selected validated language.
- Patients who are expected to be available throughout the intervention and follow-up period
Exclusion Criteria:
- Patients experiencing an acute medical condition requiring emergency treatment or hospitalization at the time of recruitment.
- Patients with severe cognitive impairment or communication difficulties that prevent meaningful participation in the intervention and completion of the assessment tools.
- Patients experiencing an acute psychiatric crisis requiring immediate specialized mental health intervention.
- Patients enrolled in another intensive remote diabetes-management program that could substantially overlap with the proposed intervention.
- Patients who decline participation or withdraw their informed consent. Note: A previous diagnosis of depression or anxiety should not automatically be an exclusion criterion unless justified by the study protocol. Including patients with stable mental health conditions may improve the applicability of the findings concerning psychological distress among diabetic patients.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Nurse led intervention and patient navigation
Participants will receive a nurse-led remote monitoring and patient navigation intervention aimed at supporting their psychological well-being and managing psychological distress over the intervention period. |
Nurse-led remote monitoring and patient navigation: refers to a structured, eight-week intervention delivered by a trained community health nurse through scheduled telephone calls or other agreed remote communication methods. It includes reviewing patients' reported health status, reinforcing diabetes self-management education, identifying barriers to healthcare access, facilitating appointments and referrals, and coordinating follow-up with healthcare providers. |
|
Sin intervención: Usual care group
Participants will receive usual care without the nurse-led remote monitoring and patient navigation intervention. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
changes in psychological distress
Periodo de tiempo: 3 months
|
Assessment of changes in psychological distress among participants using the specified psychological distress assessment scale, comparing baseline and post-intervention measurements. |
3 months
|
|
Change in Diabetes Self-Management
Periodo de tiempo: 3 months
|
Assessment of changes in diabetes self-management among participants using the specified diabetes self-management assessment tool, comparing baseline and post-intervention measurements. |
3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Doaa MANSOUR Ali, ASSISSTANT PROFESSOR, Cairo University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- HUNURSERC2026/10/67/14
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data (IPD) collected during this study will not be shared with other researchers. The data will be used exclusively for the purposes of the current study and will be kept confidential to protect participants' privacy.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .